FDA issues recall for Zantac after confirming the medication can breakdown to create NDMA a known carcinogen. On April 1st, 2020 the FDA issues the following statement. "The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly kn

Pharmaceutical giant GSK reaches major settlement despite denying carcinogenic claims, agrees to pay $2.3 billion to resolve 80,000 Zantac lawsuits | WION